You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Reboxetine

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sleep Apnea, Obstructive Trial (Reboxetine 4 MG Oral Tablet, Placebo)

Not yet recruiting
  • Sleep Apnea, Obstructive
  • Reboxetine 4 MG Oral Tablet
  • Placebo
  • (no location specified)
Jul 28, 2023

PTSD Trial in Haifa, Netanya (Methylphenidate, Reboxetine, Placebo)

Recruiting
  • Posttraumatic Stress Disorder
  • Haifa, Israel
  • +1 more
Nov 20, 2022

Fatigue Trial in Brussels (Reboxetine Pill, Methylphenidate Oral Product)

Recruiting
  • Fatigue
  • Reboxetine Pill
  • Methylphenidate Oral Product
  • Brussels, Belgium
    Brussels Labo voor Inspanning & Topsport U-residence
May 19, 2023

15 Different Antidepressants in Major Depressive Disorder

Completed
  • Major Depressive Disorder
  • Copenhagen, Denmark
    Psychiatric Center Copenhagen
Jul 18, 2023

Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)

Not yet recruiting
  • Panic Disorder
  • (no location specified)
Feb 20, 2023

Stress Urinary Incontinence, Fecal Incontinence Trial in Copenhagen (Citalopram 40mg, Reboxetine 8 mg, Placebo oral tablet)

Completed
  • Stress Urinary Incontinence
  • Fecal Incontinence
  • Citalopram 40mg
  • +2 more
  • Copenhagen, Denmark
    Department of Clinical Pharmacology, Bispebjerg and Frederiksber
Jun 8, 2021

Narcolepsy, Cataplexy, Excessive Daytime Sleepiness Trial in Canada, United States (AXS-12 (reboxetine), Placebo)

Enrolling by invitation
  • Narcolepsy
  • +2 more
  • AXS-12 (reboxetine)
  • Placebo
  • Santa Ana, California
  • +18 more
Sep 23, 2022

Depressive Disorder, Major Trial in Estonia, Russian Federation (sertraline/[S,S]-reboxetine, sertraline, Placebo)

Completed
  • Depressive Disorder, Major
  • Viljandi, Viljandi Mk., Estonia
  • +16 more
Jan 26, 2021

Narcolepsy, Cataplexy, Excessive Daytime Sleepiness Trial in Canada, United States (AXS-12 (reboxetine), Placebo)

Recruiting
  • Narcolepsy
  • +2 more
  • AXS-12 (reboxetine)
  • Placebo
  • Alabaster, Alabama
  • +45 more
Sep 23, 2022

Narcolepsy, Cataplexy Narcolepsy, Excessive Sleepiness Trial in United States (AXS-12 (Reboxetine), Placebo)

Completed
  • Narcolepsy
  • +2 more
  • AXS-12 (Reboxetine)
  • Placebo
  • Birmingham, Alabama
  • +13 more
Dec 8, 2020

Healthy Trial in Oxford (Reboxetine, Rivastigmine, Placebo oral tablet)

Completed
  • Healthy
  • Reboxetine
  • +2 more
  • Oxford, Oxfordshire, United Kingdom
    Dept of Psychiatry, University of Oxford
Jun 15, 2020

Healthy Trial in Zurich (Methylphenidate, Reboxetine, Placebos)

Completed
  • Healthy
  • Zurich, Switzerland
    University of Zurich
Apr 29, 2020

ADHD Trial (Atomoxetine, PNU-165442G; [S,S]-reboxetine)

Withdrawn
  • Attention Deficit Hyperactivity Disorder
  • (no location specified)
Apr 11, 2019

Diabetic Neuropathies Trial in Worldwide (Placebo, [S,S]-Reboxetine)

Terminated
  • Diabetic Neuropathies
  • Anniston, Alabama
  • +55 more
Dec 11, 2019

Pain Trial in Worldwide ([S,S]-Reboxetine + Pregabalin, Pregabalin)

Terminated
  • Pain
  • Huntsville, Alabama
  • +82 more
Dec 12, 2019

Fibromyalgia Trial in Canada, United States ([S,S]-Reboxetine, Placebo)

Completed
  • Fibromyalgia
  • Birmingham, Alabama
  • +144 more
Dec 10, 2019

Fibromyalgia Trial in Canada, United States ([S,S]-Reboxetine)

Terminated
  • Fibromyalgia
  • Birmingham, Alabama
  • +108 more
Dec 15, 2019

Fibromyalgia Trial in Worldwide ([S,S]-reboxetine)

Terminated
  • Fibromyalgia
  • Orangevale, California
  • +78 more
Dec 11, 2019

Depression, Depressive Disorder, MDD Trial in Boston (Aspirin 325mg, Placebo Oral Tablet)

Recruiting
  • Depression
  • +3 more
  • Aspirin 325mg
  • Placebo Oral Tablet
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 29, 2021

Depression, Anxiety Trial in Croyde (Sea swimming)

Completed
  • Depression, Anxiety
  • Sea swimming
  • Croyde, Devon, United Kingdom
    Croyde Beach
Aug 17, 2021

Depressive Disorder, Major Trial in Erlangen (Mirtazapine, Venlafaxine)

Completed
  • Depressive Disorder, Major
  • Erlangen, Bavaria, Germany
    Department of Psychiatry and Psychotherapy, University Erlangen-
Dec 10, 2020

Depression, Inflammation Trial in Oxford (Simvastatin 20mg, Placebo)

Recruiting
  • Depression
  • Inflammation
  • Simvastatin 20mg
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
    Department of Psychiatry, University of Oxford
Dec 15, 2020

Covid19 Trial in Hershey (Fluoxetine, Placebo)

Withdrawn
  • Covid19
  • Hershey, Pennsylvania
    Milton S. Hershey Medical Center Clinical Research Center
Dec 22, 2020

Vasovagal Syncope Trial in Calgary (Atomoxetine, Placebo)

Completed
Has Results
  • Vasovagal Syncope
  • Calgary, Alberta, Canada
    University of Calgary
Apr 20, 2020

Healthy Trial in Oxford (Atorvastatin 20mg, Lactose )

Completed
  • Healthy
  • Atorvastatin 20mg
  • Lactose placebo
  • Oxford, United Kingdom
    Riccardo De Giorgi
Nov 30, 2020